公司概覽
業務類別 Biotechnology
業務概覽 BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
公司地址 3160 Porter Drive, Suite 250, Palo Alto, CA, USA, 94304
電話號碼 +1 650 391-9740
傳真號碼 --
公司網頁 https://www.bridgebio.com
員工數量 839
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Neil Kumar, PhD Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc. 美元 1.04M 24/04/2026
Dr. Thomas Trimarchi, PhD President and Chief Financial Officer 美元 675.59K 24/04/2026
Ms. Maricel M. Apuli Chief Accounting Officer -- 24/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Charles J. Homcy,M.D. Lead director 24/04/2026
Mr. Fred Hassan Lead Independent Director 24/04/2026
Mr. James C. Momtazee Independent Director 24/04/2026
Dr. Frank P. McCormick, D.Sc.,F.R.S.,PhD Director 24/04/2026
Dr. Eric Aguiar, M.D. Independent Director 24/04/2026
Mr. Ali J. Satvat Independent Director 24/04/2026
Mr. Douglas A. Dachille Independent Director 24/04/2026
Dr. Neil Kumar, PhD Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc. 24/04/2026
Ms. Jennifer E. Cook Independent Director 24/04/2026
Mr. Ronald J. Daniels Independent Director 24/04/2026
Dr. Andrew W. Lo, PhD Independent Director 24/04/2026
Dr. Hannah A. Valantine, M.D. Independent Director 24/04/2026
Ms. Andrea John Ellis Independent Director 24/04/2026
 
所屬ETF (更新日期: 07/11/2026 03:53)
代號 名稱 佔比% ▼ 持有日期
RECIColumbia Research Enhanced Cor PrmIncETF0.00001%31/10/2026
AIEQAI Powered Equity ETF<0.000001%24/05/2023
BMEDiShares Health Innovation Active ETF<0.000001%19/03/2026
BRESBurney U.S. Equity Select ETF<0.000001%30/10/2026
BRNYBurney U.S. Factor Rotation ETF<0.000001%30/10/2026
CLSEConvergence Long/Short Equity ETF<0.000001%05/03/2026
CPZCalamos L/S Equity & Dynamic Inc Trust<0.000001%31/08/2026
DFAUDimensional US Core Equity Market ETF<0.000001%14/10/2026
DFUSDimensional US Equity Market ETF<0.000001%14/10/2026
FDMOFidelity Momentum Factor ETF<0.000001%15/05/2026
FFTYCapForce IBD® 50 ETF<0.000001%04/05/2026
FSCCFederated Hermes MDT Small Cap Core ETF<0.000001%02/10/2026
FSEGFidelity Enhanced Small Cap Growth ETF<0.000001%19/10/2026
FSMLFranklin Small Cap Enhanced ETF<0.000001%09/07/2026
FTLSFirst Trust Long/Short Equity ETF<0.000001%04/06/2026
FTXHFirst Trust Nasdaq Pharmaceuticals ETF<0.000001%22/03/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF<0.000001%29/06/2026
HDGProShares Hedge Replication<0.000001%29/06/2026
HIAIAi Funds High Conv US Eq AI-Mgd ETF<0.000001%28/09/2026
HKNDHumankind US Stock ETF<0.000001%24/11/2025
  1    2    3    4    5    6   7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.